P And G Ahuja Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 02-06-2024
- Paid Up Capital ₹ 5.00 M
as on 02-06-2024
- Company Age 21 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 M
as on 02-06-2024
- Revenue -60.88%
(FY 2022)
- Profit -104.66%
(FY 2022)
- Ebitda 105.60%
(FY 2022)
- Net Worth -0.19%
(FY 2022)
- Total Assets -10.89%
(FY 2022)
About P And G Ahuja Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹8.00 M.
Payal Ahuja, Nitin Ahuja, and Mukul Ahuja serve as directors at the Company.
- CIN/LLPIN
U24231GJ2003PLC043062
- Company No.
043062
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Oct 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does P And G Ahuja Biotech Limited offer?
P And G Ahuja Biotech Limited offers a wide range of products and services, including Gardening Service, Garden Developers, Fresh Flowers, Plants & Trees, Indoor Plants, Landscape Structure and Designing, Outdoor Plant, Plant Pots, Flower Pots, Garden Decor, Vertical Garden.
Who are the key members and board of directors at P And G Ahuja Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukul Ahuja  | Director | 23-Apr-2009 | Current |
| Payal Ahuja | Director | 16-Oct-2003 | Current |
| Nitin Ahuja | Director | 09-Sep-2020 | Current |
Financial Performance of P And G Ahuja Biotech.
P And G Ahuja Biotech Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 60.88% decrease. The company also saw a substantial fall in profitability, with a 104.66% decrease in profit. The company's net worth dipped by a decrease of 0.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of P And G Ahuja Biotech?
In 2019, P And G Ahuja Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Bopal Branch Creation Date: 02 Feb 2007 | ₹8.00 M | Open |
How Many Employees Work at P And G Ahuja Biotech?
Unlock and access historical data on people associated with P And G Ahuja Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of P And G Ahuja Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped P And G Ahuja Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
